Dallah Healthcare has reported a 52 percent jump in profit to $40 million in the first half of 2022, supported by an increase in patient occupancy rates.
The company’s stock however posted a 1.9 percent drop in early Tuesday trading, but then rebounded to close 0.9 percent higher at SR118.
The uptick in revenues came on the back of continued growth in operations and higher hospital admissions during the six-month period.
The company also cited an improvement in operational efficiency when compared to last year, in addition to a lower share in the losses of associates by SR1.6 million.
